Changing hepatitis A epidemiology among Hong Kong Chinese adolescents: What are the implications?

Public Health

Volumn 113, Issue 4, 1999, Pages 185-188

  Lee, A ^a   Cheng, F ^a   Lau, L ^a   Lo, A ^a   Fabb, W E ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adolescents; Changing pattern; Chinese; Hepatitis A; Hong Kong; Sero epidemiology

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

DISEASE TRANSMISSION; HEPATITIS; MEDICAL GEOGRAPHY; YOUNG POPULATION;

ADOLESCENT; ADULT; ARTICLE; CHINA; DEVELOPING COUNTRY; FOOD; HEPATITIS A; HONG KONG; HUMAN; INFECTION RATE; INFECTION RISK; SCHOOL CHILD; TRAVEL; VACCINATION;

CHINA; HONG KONG;

EID: 0032818860     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(99)00151-1     Document Type: Article

References (36)

1. Fitzner KA. Hepatitis A vaccination: a cost-benefit study in Hong Kong. Hong Kong Pract 1994; 16: 357-366.
2. Steffen R et al. Health Problems after travel to developing countries. J Infect Dis 1987; 156: 84-91.
3. Forbes A, William R. Increasing age an important adverse prognostic factor in hepatitis A infection. JR Coll Phys London 1988; 22: 237-239.
4. Leung NWY. Update on viral hepatitis A. Hong Kong Pract 1995; 17: 538-545.
5. Hsu HY et al. Changing seroepidemiology of hepatitis A virus infection in Taiwan. J Med Virol 1985; 17: 297-301.
6. Boughton CR, Hawkes RA, Ferguson V. Viral hepatitis A and B: a sero-epidemiological study of a non-hepatitic Sydney population. Med J Australia 1980; 1: 177-180.
7. Lehmann NI, Gust ID. The prevalence of antibody to hepatitis A virus in two populations in Victoria. Med J Australia 1977; 2: 731-732.
8. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis 1995; 171 (Suppl 1): S2-S8.
9. Margolis HS, Shapiro CN. Who should receive hepatitis A vaccine? Consideration for the development of an immunization strategy. Vaccine 1992; 10 (Suppl 1): S85-S87.
10. Steffen R. Hepatitis A in traveller: the European experience. J Infect Dis 1995; 171 (Supp 1): S24-S28.
11. Tsang CW, Chan CL. Epidemiology of viral hepatitis in Hong Kong in new trends in peptic ulcer and chronic hepatitis - Part II chronic hepatitis. Excerpta Medica 1987; 43-50.
12. Chin KP et al. Current sero-epidemiology of hepatitis A in Hong Kong. J Med Virol 1991; 34: 191-193.
13. Lim WL, Yeoh EK. Hepatitis A vaccination (Letter). Lancet 1992; 339: 304.
14. 1996 Population By-census: Summary Results. Census and Statistics Department: Hong Kong.
15. Hepatitis: IMx System: HAVAB. Abbot Laboratories, USA. July, 1994.
16. Statistical Package for Social Science. SPSS Inc: Chicago USA. Nov 1996.
17. Akbar SM et al. The seroepidemiology of hepatitis A and B in a Japanese Town. Asia Pac J Public Health 1992; 6: 26-29.
18. Fock KM et al. Seroprevalence of antibodies against hepatitis A in Singapore: the NFDP experience. Singapore Med J 1995; 36: 26-27.
19. Shapiro CN et al. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992; 10 (Suppl 1): S59-S62.
20. Lucas CR, Milne A, Hopkirk N. Kawerau revisited: hepatitis A and B sero-prevalence in 1984 and 1993. New Zealand Med J 1994; 107: 266-268.
21. Yap I, Guan R. Hepatitis A sero-epidemiology in Singapore: a changing pattern. Trans R Soc Trop Med Hyg 1993; 87: 22-23.
22. Hesketh LM et al. Childhood Infection with Hepatitis A and B Virus in England and Wales. Communicable Disease Report. CDR Review 1997; 7: R60-R63, Apr 4, Public Health Laboratory, Preston, U.K.
23. Gay NJ et al. Age-specific Antibody Prevalence to Hepatitis A in England: Implications for Disease Control. Epidemiol Infect 1994; 113: 113-120.
24. Tzen KT et al. Hepatitis A virus infections in Taipei City in 1989. J Formosa Med Assoc 1991; 90: 138-140.
25. Ho YY, Chan BCH. Does Hong Kong need hepatitis A vaccine? Hong Kong Med J 1995; 1: 137-139.
26. Ikematsu H et al. seroepidemiological study of hepatitis A virus infection: statistical analysis of two independent cross-sectional surveys in Okinawa, Japan. Am J Epidemiol 1987; 126: 50-54.
27. Frosner GG et al. Antibodies against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol 1979; 110: 63-69.
28. Lemon SM. Type A viral hepatitis: new development in an old disease. N Engl J Med 1985; 313: 1059-1067.
29. Scientific Working Group on Viral Hepatitis Prevention. Surveillance of Viral Hepatitis in Hong Kong. A report. Department of Health, 1996.
30. Hadler SC. Global Impact of Hepatitis A Virus Infection: Changing Patterns in Viral Hepatitis and Liver Disease, Hollinger FB, Lemon SM and Margolis H, Williams & Wilkins (eds): Baltimore, 1991, pp 14-19.
31. Hofmann F et al. Hepatitis A as an occupational hazard. Vaccine 1992; 10 (Suppl 1): S82-S84.
32. Chang HC, Wu SM, Pu CC, Yuan R. Epidemiologic and clinical studies on 3084 cases of hepatitis A in Shanghai. Chinese J Clin Hepatol 1989; 5: 201-213.
33. Mao JS et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis 1989; 159: 621-624.
34. Burke DS, Snitbhan R, Johnson DE, Scott RM. Age-specific prevalence of hepatitis a virus antibody in Thailand. Am J Epidemiol 1981; 113: 245-249.
35. Innis BL et al. The declining transmission of hepatitis A in Thailand. J Infect Dis 1991; 163: 989-995.
36. Innis BL et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994; 271: 1328-1334.